首页> 外文期刊>American journal of cardiovascular drugs: drugs, devices, and other interventions >Endovascular stents: A review of their use in peripheral arterial disease
【24h】

Endovascular stents: A review of their use in peripheral arterial disease

机译:血管支架:对外周动脉疾病的使用综述

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Technological advances in the past decade have shifted revascularization strategies from traditional open surgical approaches toward lower-morbidity percutaneous endovascular treatments for patients with lower extremity peripheral arterial disease (PAD). The continuing advances in stent design, more than any other advances, have fueled the growth of catheter-based procedures by improving the safety, durability, and predictability of percutaneous revascularization. Although the 2007 TransAtlantic Inter-Society Consensus (TASC) guidelines recommend endovascular therapy for type A and B aortoiliac and femoropopliteal lesions, recent developments in stent technology and increased experience of interventionists have suggested that a strategy of endovascular therapy first is appropriate in experienced hands for TASC type D lesions. The role of endovascular interventions is also expanding in the treatment of limb-threatening ischemia.
机译:过去十年的技术进步从传统的开放手术方法转向血型血管态度,对下肢外周动脉疾病(PAD)的患者进行经皮内血管内治疗。 支架设计的持续进步,超过任何其他进步,通过提高经皮血运重建的安全性,耐久性和可预测性来推动基于导管的程序的增长。 虽然2007年跨大西洋社会共识(TASC)指导方针建议血管内治疗A和B Aortoilitia和股骨头上的病变,但是近期支架技术的发展和干预措施的增加经验表明,血管内治疗的策略首先是适合于经验丰富的手 Tasc型D病灶。 血管内干预的作用也在治疗肢体威胁性缺血中扩大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号